A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.
暂无分享,去创建一个
O. Kallioniemi | J. Kononen | H. Nevanlinna | H. Eerola | J. Bartek | K. Aittomäki | C. Blomqvist | P. Vahteristo | J. Bártková | K. Syrjäkoski | S. Ojala | O. Kilpivaara | A. Tamminen | P. Heikkilä | K. Holli | K. Syrjäkoski | Salla Ojala
[1] A Sajantila,et al. Identification of individuals by analysis of biallelic DNA markers, using PCR and solid-phase minisequencing. , 1993, American journal of human genetics.
[2] O. Kallioniemi,et al. Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes. , 1997, Human molecular genetics.
[3] S. Elledge,et al. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.
[4] B. Ponder,et al. A Systematic Review Of Genetic Polymorphisms and Breast Cancer Risk 1 , 2000 .
[5] K. Isselbacher,et al. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.
[6] T. Halazonetis,et al. Chk2/hCds1 functions as a DNA damage checkpoint in G(1) by stabilizing p53. , 2000, Genes & development.
[7] Jong-Soo Lee,et al. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response , 2000, Nature.
[8] H. Konishi,et al. Histological type-selective, tumor-predominant expression of a novel CHK1 isoform and infrequent in vivo somatic CHK2 mutation in small cell lung cancer. , 2000, Cancer research.
[9] S. Elledge,et al. Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[10] H. Nevanlinna,et al. Familial breast cancer in southern Finland: how prevalent are breast cancer families and can we trust the family history reported by patients? , 2000, European journal of cancer.
[11] K Holli,et al. Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. , 2000, Journal of the National Cancer Institute.
[12] Y Taya,et al. The human homologs of checkpoint kinases Chk1 and Cds1 (Chk2) phosphorylate p53 at multiple DNA damage-inducible sites. , 2000, Genes & development.
[13] S. Elledge,et al. The DNA damage response: putting checkpoints in perspective , 2000, Nature.
[14] M. Kastan,et al. The many substrates and functions of ATM , 2000, Nature Reviews Molecular Cell Biology.
[15] Carl W. Miller,et al. Analysis of the CHK2 Gene in Lymphoid Malignancies , 2001, Leukemia & lymphoma.
[16] Jing Chen,et al. Characterization of Tumor-associated Chk2 Mutations* , 2001, The Journal of Biological Chemistry.
[17] D. Sgroi,et al. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome. , 2001, Cancer research.
[18] W. Hofmann,et al. Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias. , 2001, Leukemia research.
[19] J. Bartek,et al. Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours , 2001, Oncogene.
[20] N E Day,et al. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population‐based study , 2001, Genetic epidemiology.
[21] H. Nevanlinna,et al. A probability model for predicting BRCA1 and BRCA2 mutations in breast and breast-ovarian cancer families , 2001, British Journal of Cancer.
[22] N. Mailand,et al. DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology. , 2001, Cancer research.
[23] J. Bartek,et al. Chk2 kinase — a busy messenger , 2001, Nature Reviews Molecular Cell Biology.
[24] L. Aaltonen,et al. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. , 2001, Cancer research.
[25] Nazneen Rahman,et al. Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations , 2002, Nature Genetics.
[26] N E Day,et al. A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes , 2002, British Journal of Cancer.
[27] Carl W. Miller,et al. Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors , 2002, Genes, chromosomes & cancer.
[28] H. Nevanlinna,et al. Risk of cancer in BRCA1 and BRCA2 mutation-positive and -negative breast cancer families (Finland) , 2001, Cancer Causes & Control.